STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVA
  4. [Form 4] Enova International, Inc. Insider Trading Activity

Enova (ENVA) Form 4: CEO nets $149K in pre-plan share sale

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Form 4 highlights for Enova International, Inc. (ENVA): On 06/20/2025, Chief Executive Officer and Director David Fisher exercised 2,000 non-qualified stock options at an exercise price of $23.96 (code “M”) and immediately sold the same 2,000 common shares in the open market at a weighted-average price of $98.4214 (code “S”).

• Gross spread captured: approximately $74.46 per share, or roughly $149,000 in pre-tax proceeds.
• Remaining direct ownership: 348,223 common shares after the transactions, down from 350,223.
• Outstanding options: 170,562 options remain unexercised on the same grant, expiring 02/12/2026. The option set vested in three equal tranches between 2020 and 2022.

The sale was executed under Fisher’s established Rule 10b5-1 trading plan, limiting the informational signal for investors. The option/SAR pair was granted with a limited stock-appreciation right that becomes exercisable only upon a Change in Control scenario; exercising the option automatically terminates the corresponding SAR.

Materiality assessment: The transaction represents less than 1% of Fisher’s total common-stock holdings and does not involve new share issuance or company-level cash flows. Therefore, the filing is viewed as routine insider portfolio management, with negligible direct effect on Enova’s capital structure or near-term financial outlook.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small, pre-planned insider sale—neutral signal, minimal ownership change.

Fisher’s option exercise at $23.96 and same-day sale at $98.42 realises a standard executive gain while trimming ownership by about 0.6%. Because the disposal was executed under a Rule 10b5-1 plan, it does not necessarily indicate forward-looking sentiment. ENVA’s share count and cash position remain unchanged; thus valuation models are unaffected. Investors should track cumulative insider selling but this single trade is unlikely to move the stock.

TL;DR: Governance-compliant trade; 10b5-1 plan mitigates conflict concerns.

The filing demonstrates adherence to SEC best practices: advance 10b5-1 planning, transparent weighted-average pricing disclosure, and clear option/SAR mechanics. Limited size and continued sizeable holding (348k shares) suggest alignment with shareholders remains intact. I classify the governance impact as neutral.

Insider Fisher David
Role Chief Executive Officer
Sold 2,000 shs ($197K)
Approx. gross sale proceeds $197K
Approx. exercise cost $48K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) with limited SAR 2,000 $0.00 $0.00
Exercise Common stock, par value $0.00001 per share 2,000 $23.96 $48K
Sale Common stock, par value $0.00001 per share 2,000 $98.4214 $197K
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 170,562 shares (Direct); Common stock, par value $0.00001 per share — 348,223 shares (Direct)
Footnotes (5)
  1. F1. The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.
  2. F2. This transaction was executed in multiple trades at prices ranging from $98.01 to $98.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
  3. F3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
  4. F4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
  5. F5. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fisher David
(Last) (First) (Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600
(Street)
CHICAGO IL 60604
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.00001 per share 06/20/2025 M 2,000 A $23.96 350,223 D
Common stock, par value $0.00001 per share 06/20/2025 S(1) 2,000 D $98.4214(2) 348,223 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4) $23.96 06/20/2025 M 2,000 (5) 02/12/2026 Common stock; par value $0.00001 per share 2,000 $0 170,562 D
Explanation of Responses:
1. The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.
2. This transaction was executed in multiple trades at prices ranging from $98.01 to $98.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
5. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.
/s/ Sean Rahilly, as attorney in fact 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR